AR012181A1 - Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. - Google Patents
Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.Info
- Publication number
- AR012181A1 AR012181A1 ARP980101380A ARP980101380A AR012181A1 AR 012181 A1 AR012181 A1 AR 012181A1 AR P980101380 A ARP980101380 A AR P980101380A AR P980101380 A ARP980101380 A AR P980101380A AR 012181 A1 AR012181 A1 AR 012181A1
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- hydrogen
- substituted
- formula
- pirimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Derivados de pirimidina novedosos de la formula (I) o las sales farmacéuticamente aceptables de los mismos que poseen una excelente actividadantisecretora, a las composiciones farmacéuticas que los contienen como un ingrediente activo, a sus intermediarios novedosos y a los procedimientos parala preparacion de los mismos. Los derivados de pirimidina poseen la formula (I) donde: Cuando A es piperidin-1-il o -NH-B, en la que B es alquilo C3-C4,alquenilo C3-C4, cicloalquilo C3-C, alcoxietilo C1-C3, feniletilo que puede estar sustituído o no, 3-trifluometilfenilmetilo, 1-naftilmetilo,4-metiltiazol-2-il o 4-feniltiazol-2-il, R1 es hidrogeno o metilo; y R2, R3, R4 y R5 son hidrogeno; o cuando A es un grupo de la formula (II):Cuando R1 eshidroximetilo o alcoximetilo C1-C3, R2, R3, R4, R5 y R6 son hidrogeno o metilo, R7 es hidrogeno o halogeno; y una o dos de R2, R3, R4, R5 y R6 son hidroxi,metoxi o un grupo de la formula (III) donde X es alquilo C1-C4, alquenilo C1-C4 sustituido o no, cicloalquilo, benciloxialquilo, alcoxicarbonilo,morfolinometilo, piperidinometilo, 4-piperazino-sustituido-metilo, fenilo sustituido o no, naftilo, bencilo sustituido o no, tiofen-2-il-metilo,1-pirrolidin-sustituido-2-il o -CHR8NHR9, donde R6 es hidrogeno, metilo, isopropilo, bencilo, benciloximetilo, metiltioetilo, benciloxicarbonilmetilo,carbamoilmetilo, carbamoiletilo o 1-bencilimidazol-4-il-metil y R9 es hidrogeno o t-butoxicarbonilo; y las otras son hidrogeno o metilo. Los intermediariosposeen la formula (VII) donde R1 es hidrogeno o metilo, una o dos de R2, R3y R5 son hidroxi o metoxi y las otras son hidrogeno o metilo; R4 eshidrogeno o metilo o las sales farmacéuticamente aceptables de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19970010862 | 1997-03-27 | ||
KR19970010863 | 1997-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012181A1 true AR012181A1 (es) | 2000-09-27 |
Family
ID=26632616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101380A AR012181A1 (es) | 1997-03-27 | 1998-03-26 | Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6352993B1 (es) |
EP (1) | EP1015444B1 (es) |
JP (1) | JP3176379B2 (es) |
KR (1) | KR100278857B1 (es) |
CN (1) | CN1118464C (es) |
AR (1) | AR012181A1 (es) |
AT (1) | ATE241613T1 (es) |
AU (1) | AU720385B2 (es) |
BR (1) | BR9808070A (es) |
CA (1) | CA2284795C (es) |
DE (1) | DE69815126T2 (es) |
DK (1) | DK1015444T3 (es) |
ES (1) | ES2200324T3 (es) |
HK (1) | HK1026418A1 (es) |
HU (1) | HUP0000851A3 (es) |
IN (1) | IN188411B (es) |
PT (1) | PT1015444E (es) |
RU (1) | RU2203894C2 (es) |
TR (1) | TR199902383T2 (es) |
TW (1) | TW542831B (es) |
UY (1) | UY24938A1 (es) |
WO (1) | WO1998043968A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
TW200302728A (en) | 2002-02-01 | 2003-08-16 | Novartis Ag | Substituted amines as IgE inhibitors |
CA2493618A1 (en) | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
AU2004259346A1 (en) * | 2003-07-22 | 2005-02-03 | Neurogen Corporation | Substituted pyridin-2-ylamine analogues |
EP1678168B1 (en) * | 2003-10-24 | 2012-07-11 | Exelixis, Inc. | P70s6 kinase modulators and method of use |
CN1874772A (zh) | 2003-11-03 | 2006-12-06 | 阿斯利康(瑞典)有限公司 | 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物 |
KR101122376B1 (ko) * | 2005-03-09 | 2012-03-26 | 주식회사유한양행 | 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법 |
WO2007042571A1 (en) * | 2005-10-14 | 2007-04-19 | Neurosearch A/S | Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
EP2308877B1 (en) | 2008-08-05 | 2014-01-22 | Daiichi Sankyo Company, Limited | Imidazopyridin-2-one derivatives |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
KR20140003438A (ko) | 2010-11-15 | 2014-01-09 | 카톨리에케 유니버시테이트 루벤 | 항바이러스성 축합 헤테로사이클릭 화합물 |
KR101671341B1 (ko) * | 2011-02-25 | 2016-11-01 | 주식회사유한양행 | 다이아미노피리미딘 유도체 및 그의 제조방법 |
WO2013123401A1 (en) * | 2012-02-17 | 2013-08-22 | Abbvie Inc. | Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv) |
CA2873674A1 (en) | 2012-05-29 | 2013-12-05 | Momentive Performance Materials Gmbh | Preparation of isocyanato silanes |
CN104918919A (zh) | 2012-11-21 | 2015-09-16 | Ptc医疗公司 | 取代的反向嘧啶Bmi-1抑制剂 |
CN105980386B (zh) | 2013-03-13 | 2021-08-13 | 基因泰克公司 | 吡唑并化合物及其用途 |
US10370371B2 (en) * | 2013-08-30 | 2019-08-06 | Ptc Therapeutics, Inc. | Substituted pyrimidine Bmi-1 inhibitors |
CN104903312B (zh) * | 2013-10-07 | 2019-01-29 | 卡德门企业有限公司 | Rho激酶抑制剂 |
EP3071553A4 (en) | 2013-11-21 | 2017-08-02 | PTC Therapeutics, Inc. | Substituted pyridine and pyrazine bmi-1 inhibitors |
CN107206004A (zh) * | 2014-10-22 | 2017-09-26 | 德克萨斯大学系统董事会 | 靶向盘状结构域受体1的小分子抑制剂及其用途 |
CN105669642B (zh) * | 2014-11-19 | 2020-06-09 | 江苏天士力帝益药业有限公司 | 一种盐酸洛氟普啶的制备方法 |
PL3400217T3 (pl) * | 2016-01-04 | 2022-07-04 | Merck Serono S.A. | L-walinian pochodnej hydroksypropylotiazolidynokarboksyamidu, jego sól i postać krystaliczna |
US11477982B2 (en) * | 2017-04-05 | 2022-10-25 | Bayer Cropscience Aktiengesellschaft | 2-amino-5-oxyalkyl-pyrimidine derivatives and their use for controlling undesired plant growth |
CN114685369B (zh) * | 2022-05-17 | 2024-02-02 | 河南省科学院高新技术研究中心 | 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1182584A (en) | 1966-03-31 | 1970-02-25 | Ici Ltd | Pyrimidine derivates and the use thereof as fungicides |
US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
US4000138A (en) | 1966-03-31 | 1976-12-28 | Imperial Chemical Industries Limited | Organic compounds and compositions containing them |
GB1383409A (en) | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
US4044136A (en) | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
US3956495A (en) | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
US4755218A (en) | 1985-12-31 | 1988-07-05 | Monsanto Company | Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
US4966622A (en) | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
DE3901448A1 (de) | 1989-01-19 | 1990-07-26 | Basf Ag | Emulsionscopolymerisate |
EP0388838B1 (de) | 1989-03-22 | 1996-01-10 | Ciba-Geigy Ag | Schädlingsbekämpfungsmittel |
GB8910722D0 (en) | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
CA2015981A1 (en) * | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
GB9012592D0 (en) | 1990-06-06 | 1990-07-25 | Smithkline Beecham Intercredit | Compounds |
HUT64533A (en) | 1990-11-06 | 1994-01-28 | Pfizer | Method for producing quinazoline derivatives for improving anti-tumoric activity and preparations containing said compounds |
EP0580753B1 (en) | 1991-04-17 | 1995-03-01 | Pfizer Inc. | Pyrimidine derivatives for enhancing antitumor activity |
US5276186A (en) | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
KR0144833B1 (ko) | 1992-12-28 | 1998-07-15 | 김태훈 | 신규의 퀴나졸린 유도체 및 그의 제조방법 |
DE69408750T2 (de) | 1993-08-26 | 1998-07-23 | Ono Pharmaceutical Co | 4-Aminopyrimidin Derivate |
RU2153494C2 (ru) | 1993-10-12 | 2000-07-27 | Дзе Дюпон Мерк Фармасьютикал Компани | 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция |
DE69530989T2 (de) * | 1994-08-13 | 2004-05-19 | Yuhan Corp. | Neue pyrimidinderivate und verfahren zu ihrer herstellung |
PT900214E (pt) * | 1996-05-04 | 2002-03-28 | Yuhan Corp | Processo para a preparacao de derivados da pirimidina |
-
1998
- 1998-03-23 IN IN724DE1998 patent/IN188411B/en unknown
- 1998-03-24 JP JP54148798A patent/JP3176379B2/ja not_active Expired - Fee Related
- 1998-03-24 WO PCT/KR1998/000058 patent/WO1998043968A1/en active IP Right Grant
- 1998-03-24 PT PT98911242T patent/PT1015444E/pt unknown
- 1998-03-24 CA CA002284795A patent/CA2284795C/en not_active Expired - Fee Related
- 1998-03-24 AT AT98911242T patent/ATE241613T1/de not_active IP Right Cessation
- 1998-03-24 EP EP98911242A patent/EP1015444B1/en not_active Expired - Lifetime
- 1998-03-24 DE DE69815126T patent/DE69815126T2/de not_active Expired - Fee Related
- 1998-03-24 ES ES98911242T patent/ES2200324T3/es not_active Expired - Lifetime
- 1998-03-24 RU RU99122603/04A patent/RU2203894C2/ru not_active IP Right Cessation
- 1998-03-24 AU AU65239/98A patent/AU720385B2/en not_active Ceased
- 1998-03-24 CN CN98803765A patent/CN1118464C/zh not_active Expired - Fee Related
- 1998-03-24 DK DK98911242T patent/DK1015444T3/da active
- 1998-03-24 US US09/381,814 patent/US6352993B1/en not_active Expired - Fee Related
- 1998-03-24 HU HU0000851A patent/HUP0000851A3/hu unknown
- 1998-03-24 TR TR1999/02383T patent/TR199902383T2/xx unknown
- 1998-03-24 BR BR9808070-9A patent/BR9808070A/pt not_active Application Discontinuation
- 1998-03-26 AR ARP980101380A patent/AR012181A1/es unknown
- 1998-03-26 UY UY24938A patent/UY24938A1/es not_active IP Right Cessation
- 1998-03-27 TW TW087104605A patent/TW542831B/zh not_active IP Right Cessation
- 1998-03-27 KR KR1019980010754A patent/KR100278857B1/ko not_active IP Right Cessation
-
2000
- 2000-09-05 HK HK00105563A patent/HK1026418A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1015444B1 (en) | 2003-05-28 |
BR9808070A (pt) | 2000-03-08 |
JP3176379B2 (ja) | 2001-06-18 |
RU2203894C2 (ru) | 2003-05-10 |
TR199902383T2 (xx) | 2000-06-21 |
ATE241613T1 (de) | 2003-06-15 |
HK1026418A1 (en) | 2000-12-15 |
KR19980080789A (ko) | 1998-11-25 |
UY24938A1 (es) | 2001-01-31 |
CN1118464C (zh) | 2003-08-20 |
TW542831B (en) | 2003-07-21 |
CA2284795C (en) | 2004-01-20 |
DK1015444T3 (da) | 2003-08-18 |
IN188411B (es) | 2002-09-21 |
JP2000513014A (ja) | 2000-10-03 |
DE69815126T2 (de) | 2004-04-08 |
DE69815126D1 (de) | 2003-07-03 |
AU720385B2 (en) | 2000-06-01 |
AU6523998A (en) | 1998-10-22 |
HUP0000851A1 (hu) | 2001-04-28 |
US6352993B1 (en) | 2002-03-05 |
HUP0000851A3 (en) | 2002-04-29 |
KR100278857B1 (ko) | 2001-01-15 |
PT1015444E (pt) | 2003-10-31 |
ES2200324T3 (es) | 2004-03-01 |
CA2284795A1 (en) | 1998-10-08 |
WO1998043968A1 (en) | 1998-10-08 |
EP1015444A1 (en) | 2000-07-05 |
CN1251586A (zh) | 2000-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012181A1 (es) | Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. | |
AR030959A1 (es) | Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen | |
AR038883A1 (es) | Compuestos que modulan la actividad de ppar, composicion farmaceutica que los contiene y un metodo para prepararlos | |
AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
PE72899A1 (es) | Derivados sulfonamida | |
AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
PE20020566A1 (es) | DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA | |
AR036046A1 (es) | Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos | |
AR019427A1 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion | |
EA200401172A1 (ru) | Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии | |
CO5011090A1 (es) | Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos | |
DK0704448T3 (da) | Nye imidazolidiner substitueret med en heterocyklisk forbindelse, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
BRPI0516748B8 (pt) | pirimidinas 5-substituídas inibidoras de hiv e composição farmacêutica que as compreende | |
ES2039242T3 (es) | Un procedimiento para la preparacion de nuevos derivados de piperidina. | |
HUP9904215A2 (hu) | Alfa-2-adrenoreceptor agonistákként alkalmazható [(2-imidazolidinilidén)-amino]-indol-származékok | |
BR9102322A (pt) | Derivados de morfolino-ureia,processo para sua preparacao,composicoes inseticidas e acaricidas,processo para o combate de insetos e acaros,utilizacao e processo para a preparacao de composicoes | |
AR005338A1 (es) | Derivados acetidinalquilicos de heterociclos con nitrogeno n-sustituido o sales farmaceuticamente aceptables de los mismos, un procedimiento paraprepararlos, composiciones farmaceuticas que los comprenden, uso de dichos derivados, sales y composiciones, y compuestos utilizables como intermedios | |
ES2032384T3 (es) | Procedimiento para preparar derivados de carboxamidas. | |
MX9101236A (es) | Procedimiento para la preparacion de compuestos azabiciclicos | |
ES2061710T3 (es) | Nuevos derivados de l-prolina, su preparacion y sus aplicaciones biologicas. | |
DK425382A (da) | Fremgangsmaade til fremstilling af amider | |
YU13899A (sh) | Pirolidinil i pirolinil etilaminska jedinjenja kao kapa agonisti | |
AR017250A1 (es) | Compuestos derivados cis-substituidos de fluorometilpirrolidina, sus sales o hidratos, utiles como agentes antibacterianos, medicamento, agenteantibacteriano, y compuestos intermediarios. | |
ES2165410T3 (es) | Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |